Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Canakinumab in recessive dystrophic epidermolysis bullosa: a novel unexpected weapon for non-healing wounds?

Clinical and experimental rheumatology - 1 Jan 2000

Annicchiarico Giuseppina, Lopalco Giuseppe, Morgese Maria Grazia, Cantarini Luca, Iannone Florenzo

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Humanized
Share to Collagen Type VII
Share to Epidermolysis Bullosa Dystrophica

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Recessive

Share to Immunosuppressive Agents

Share to Recurrence

Share to Wound Healing

Source

Identifiers

PMID: 26885873

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Canakinumab in recessive dystrophic epidermolysis bullosa: a novel unexpected weapon for non-healing wounds?PMID 26885873Read ↗

Treatment of Epidermolysis Bullosa and Future Directions: A ReviewSemantic proximity Read ↗

Current Treatment Landscape for Dystrophic Epidermolysis Bullosa: From Surgical Management to Emerging Gene Therapies and Novel Skin GraftsSemantic proximity Read ↗

Newer treatment modalities in epidermolysis bullosaSemantic proximity Read ↗

Current topics in Epidermolysis bullosa: Pathophysiology and therapeutic challenges.Semantic proximity Read ↗

Stairways to Advanced Therapies for Epidermolysis Bullosa.Semantic proximity Read ↗

Therapies for genetic extracellular matrix diseases of the skin.Semantic proximity Read ↗

Recent advances in understanding and managing epidermolysis bullosaSemantic proximity Read ↗

Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosaSemantic proximity Read ↗

Emerging Gene Therapeutics for Epidermolysis Bullosa under Development.Semantic proximity Read ↗

Small molecule drug development for rare genodermatoses - evaluation of the current status in epidermolysis bullosa.Semantic proximity Read ↗

Skin Fragility: Perspectives on Evidence-based Therapies.Semantic proximity Read ↗

Epidermolysis bullosa: scientific advances and therapeutic challenges.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.